These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

272 related articles for article (PubMed ID: 22815558)

  • 1. Serum ceramides increase the risk of Alzheimer disease: the Women's Health and Aging Study II.
    Mielke MM; Bandaru VV; Haughey NJ; Xia J; Fried LP; Yasar S; Albert M; Varma V; Harris G; Schneider EB; Rabins PV; Bandeen-Roche K; Lyketsos CG; Carlson MC
    Neurology; 2012 Aug; 79(7):633-41. PubMed ID: 22815558
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Circulating ceramide ratios and risk of vascular brain aging and dementia.
    McGrath ER; Himali JJ; Xanthakis V; Duncan MS; Schaffer JE; Ory DS; Peterson LR; DeCarli C; Pase MP; Satizabal CL; Vasan RS; Beiser AS; Seshadri S
    Ann Clin Transl Neurol; 2020 Feb; 7(2):160-168. PubMed ID: 31950603
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Association Between Plasma Ceramides and Sphingomyelins and Risk of Alzheimer's Disease Differs by Sex and APOE in the Baltimore Longitudinal Study of Aging.
    Mielke MM; Haughey NJ; Han D; An Y; Bandaru VVR; Lyketsos CG; Ferrucci L; Resnick SM
    J Alzheimers Dis; 2017; 60(3):819-828. PubMed ID: 28035934
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Serum sphingomyelins and ceramides are early predictors of memory impairment.
    Mielke MM; Bandaru VV; Haughey NJ; Rabins PV; Lyketsos CG; Carlson MC
    Neurobiol Aging; 2010 Jan; 31(1):17-24. PubMed ID: 18455839
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Plasma ceramides are altered in mild cognitive impairment and predict cognitive decline and hippocampal volume loss.
    Mielke MM; Haughey NJ; Bandaru VV; Schech S; Carrick R; Carlson MC; Mori S; Miller MI; Ceritoglu C; Brown T; Albert M; Lyketsos CG
    Alzheimers Dement; 2010 Sep; 6(5):378-85. PubMed ID: 20813340
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Differential associations of plasma lipids with incident dementia and dementia subtypes in the 3C Study: A longitudinal, population-based prospective cohort study.
    Schilling S; Tzourio C; Soumaré A; Kaffashian S; Dartigues JF; Ancelin ML; Samieri C; Dufouil C; Debette S
    PLoS Med; 2017 Mar; 14(3):e1002265. PubMed ID: 28350817
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Plasma sphingomyelins are associated with cognitive progression in Alzheimer's disease.
    Mielke MM; Haughey NJ; Bandaru VV; Weinberg DD; Darby E; Zaidi N; Pavlik V; Doody RS; Lyketsos CG
    J Alzheimers Dis; 2011; 27(2):259-69. PubMed ID: 21841258
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sphingomyelins and ceramides: possible biomarkers for dementia?
    Loft LMI; Moseholm KF; Pedersen KKW; Jensen MK; Koch M; Cronjé HT
    Curr Opin Lipidol; 2022 Feb; 33(1):57-67. PubMed ID: 34879042
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Plasma beta amyloid and the risk of Alzheimer disease and dementia in elderly men: a prospective, population-based cohort study.
    Sundelöf J; Giedraitis V; Irizarry MC; Sundström J; Ingelsson E; Rönnemaa E; Arnlöv J; Gunnarsson MD; Hyman BT; Basun H; Ingelsson M; Lannfelt L; Kilander L
    Arch Neurol; 2008 Feb; 65(2):256-63. PubMed ID: 18268197
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Plasma Ceramides and Neuropsychiatric Symptoms of Alzheimer's Disease.
    Xing Y; Tang Y; Zhao L; Wang Q; Qin W; Zhang JL; Jia J
    J Alzheimers Dis; 2016 Apr; 52(3):1029-35. PubMed ID: 27079712
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Circulating Ceramides Predict Cardiovascular Outcomes in the Population-Based FINRISK 2002 Cohort.
    Havulinna AS; Sysi-Aho M; Hilvo M; Kauhanen D; Hurme R; Ekroos K; Salomaa V; Laaksonen R
    Arterioscler Thromb Vasc Biol; 2016 Dec; 36(12):2424-2430. PubMed ID: 27765765
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Plasma Ceramides, Mediterranean Diet, and Incident Cardiovascular Disease in the PREDIMED Trial (Prevención con Dieta Mediterránea).
    Wang DD; Toledo E; Hruby A; Rosner BA; Willett WC; Sun Q; Razquin C; Zheng Y; Ruiz-Canela M; Guasch-Ferré M; Corella D; Gómez-Gracia E; Fiol M; Estruch R; Ros E; Lapetra J; Fito M; Aros F; Serra-Majem L; Lee CH; Clish CB; Liang L; Salas-Salvadó J; Martínez-González MA; Hu FB
    Circulation; 2017 May; 135(21):2028-2040. PubMed ID: 28280233
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comment: serum ceramides--a new biomarker for preclinical AD?
    Pavlik V
    Neurology; 2012 Aug; 79(7):639. PubMed ID: 22815553
    [No Abstract]   [Full Text] [Related]  

  • 14. Plasma Ceramides and Sphingomyelins in Relation to Atrial Fibrillation Risk: The Cardiovascular Health Study.
    Jensen PN; Fretts AM; Hoofnagle AN; Sitlani CM; McKnight B; King IB; Siscovick DS; Psaty BM; Heckbert SR; Mozaffarian D; Sotoodehnia N; Lemaitre RN
    J Am Heart Assoc; 2020 Feb; 9(4):e012853. PubMed ID: 32019406
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Low-density lipoprotein cholesterol and the risk of dementia with stroke.
    Moroney JT; Tang MX; Berglund L; Small S; Merchant C; Bell K; Stern Y; Mayeux R
    JAMA; 1999 Jul; 282(3):254-60. PubMed ID: 10422994
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Association of plasma leptin levels with incident Alzheimer disease and MRI measures of brain aging.
    Lieb W; Beiser AS; Vasan RS; Tan ZS; Au R; Harris TB; Roubenoff R; Auerbach S; DeCarli C; Wolf PA; Seshadri S
    JAMA; 2009 Dec; 302(23):2565-72. PubMed ID: 20009056
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ceramide Remodeling and Risk of Cardiovascular Events and Mortality.
    Peterson LR; Xanthakis V; Duncan MS; Gross S; Friedrich N; Völzke H; Felix SB; Jiang H; Sidhu R; Nauck M; Jiang X; Ory DS; Dörr M; Vasan RS; Schaffer JE
    J Am Heart Assoc; 2018 May; 7(10):. PubMed ID: 29728014
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Serum cholesterol and risk of Alzheimer disease: a community-based cohort study.
    Li G; Shofer JB; Kukull WA; Peskind ER; Tsuang DW; Breitner JC; McCormick W; Bowen JD; Teri L; Schellenberg GD; Larson EB
    Neurology; 2005 Oct; 65(7):1045-50. PubMed ID: 16217057
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Serum cystatin C and the risk of Alzheimer disease in elderly men.
    Sundelöf J; Arnlöv J; Ingelsson E; Sundström J; Basu S; Zethelius B; Larsson A; Irizarry MC; Giedraitis V; Rönnemaa E; Degerman-Gunnarsson M; Hyman BT; Basun H; Kilander L; Lannfelt L
    Neurology; 2008 Sep; 71(14):1072-9. PubMed ID: 18824671
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Circulating fibroblast growth factor 23 levels and incident dementia: The Framingham heart study.
    McGrath ER; Himali JJ; Levy D; Conner SC; Pase MP; Abraham CR; Courchesne P; Satizabal CL; Vasan RS; Beiser AS; Seshadri S
    PLoS One; 2019; 14(3):e0213321. PubMed ID: 30830941
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.